Delivery Order SPE2DB20D1109-SPE2DB25FP12K
Award Date
5/23/25
Potential Completion Date
5/27/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $22,692.39 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of 4% Lidocaine HCL Solution (4 ml). The contract has an ultimate completion date of May 4, 2023. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,943,632 units of 4% Lidocaine HCL Solution in 4ml vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,046.26 and a performance period through April 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,240.24 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4% lidocaine hydrochloride solution. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies in support of...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of 4% Lidocaine HCL in 50mL units, with a firm fixed price of $1,001.41 and a completion date of December 27, 2023. This is a delivery order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp has previously received multiple...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,234.54 firm fixed price contract is for the supply of Lidocaine HCL 4% Solution 4ML, a medication product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,057 firm fixed-price delivery order is for the supply of 4% Lidocaine HCL solution, a medical product used in various healthcare settings. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,011.32 order is for the supply of Lidocaine HCL 4% Solution 4ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The delivery order, valued at $1,233.12, is for the supply of 4% Lidocaine Hydrochloride Solution, a medical product used for pain management. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,509.92, is for the delivery of 4567376999 - Lidocaine HCL 4% Solution 4ML. This is a firm-fixed-price contract with a completion date of February 26, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lidocaine HCL 4% Solution 4ML. The contract has a ceiling value of $3,460.84 and is a firm fixed price arrangement. The place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...